ATHALTERITY THERAPEUTICS LIMITEDMarket sensitive

Alterity and FDA Agree on Phase 3 Program for ATH434 in MSA

Date and time
Announcement type
Company Update

More from Health Care

More News

VR8Company Update5 October 2026

Vanadium Resources (ASX: VR8) Maps US$842m V-Iron Case